T1	Participants 136 185	following adjuvant chemotherapy for breast cancer
T2	Participants 494 511	for breast cancer
T3	Participants 807 858	for chemotherapy-naïve patients with breast cancer
T4	Participants 1080 1085	to 8.
T5	Participants 1086 1239	Median age of the 94 women was 51 years (range 27-76): 79 received fluorouracil/epirubicin/cyclophosphamide and 15 received doxorubicin/cyclophosphamide
